Delivery of intravenous anti‐cancer therapy at home versus in hospital or community settings for adults with cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Delivery of Intravenous Anti‐cancer Therapy at Home Versus in Hospital or Community Settings for Adults With Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437811/all/Melatonin_for_women_in_pregnancy_for_neuroprotection_of_the_fetus_New. Accessed 18 April 2024.
Delivery of intravenous anti‐cancer therapy at home versus in hospital or community settings for adults with cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437811/all/Melatonin_for_women_in_pregnancy_for_neuroprotection_of_the_fetus_New. Accessed April 18, 2024.
Delivery of intravenous anti‐cancer therapy at home versus in hospital or community settings for adults with cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437811/all/Melatonin_for_women_in_pregnancy_for_neuroprotection_of_the_fetus_New
Delivery of Intravenous Anti‐cancer Therapy at Home Versus in Hospital or Community Settings for Adults With Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437811/all/Melatonin_for_women_in_pregnancy_for_neuroprotection_of_the_fetus_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Delivery of intravenous anti‐cancer therapy at home versus in hospital or community settings for adults with cancer
ID - 437811
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437811/all/Melatonin_for_women_in_pregnancy_for_neuroprotection_of_the_fetus_New
DB - Evidence Central
DP - Unbound Medicine
ER -